Back

2019 novel coronavirus disease in hemodialysis (HD) patients: Report from one HD center in Wuhan, China

Ma, Y.; Diao, B.; Lv, X.; Zhu, J.; Liang, W.; Liu, L.; Bu, W.; Cheng, H.; Zhang, S.; Shi, M.; Ding, G.; Shen, B.; Wang, H.

2020-02-25 nephrology
10.1101/2020.02.24.20027201 medRxiv
Show abstract

ImportanceThe outbreak of highly contagious COVID-19 has posed a serious threat to human health, especially for those with underlying diseases. However, Impacts of COVID-19 epidemic on HD center and HD patients have not been reported. ObjectiveTo summery an outbreak of COVID-19 epidemic in HD center. Design, Setting, and ParticipantsWe reviewed the epidemic course from the first laboratory-confirmed case of COVID-19 infection on January 14 to the control of the epidemic on March 12 in the HD center of Renmin Hospital of Wuhan University. Total 230 HD patients and 33 medical staff were included in this study ExposuresCOVID-19. Main Outcomes and MeasuresEpidemiological, clinical, laboratory, and radiological characteristics and outcomes data were collected and analyzed. 19 COVID-19 HD patients, 19 non-COVID-19 HD patients and 19 healthy volunteers were enrolled for further study about the effect of SARS-CoV-2 infection on host immune responses. Results42 out of 230 HD patients (18.26%) and 4 out of 33 medical staffs (12.12%) were diagnosed with COVID-19 from the outbreak to March 12, 2020. 13 HD patients (5.65%), including 10 COVID-19 diagnosed, died during the epidemic. Only 2 deaths of the COVID-19 HD patients were associated with pneumonia/lung failure. Except 3 patients were admitted to ICU for severe condition (8.11%), including 2 dead, most COVID-19 diagnosed patients presented mild or none-respiratory symptoms. Multiple lymphocyte populations in HD patients were significantly decreased. HD patients with COVID-19 even displayed more remarkable reduction of serum inflammatory cytokines than other COVID-19 patients. Conclusions and RelevanceHD patients are the highly susceptible population and HD centers are high risk area during the outbreak of COVID-19 epidemic. HD Patients with COVID-19 are mostly clinical mild and unlikely progress to severe pneumonia due to the impaired cellular immune function and incapability of mounting cytokines storm. More attention should be paid to prevent cardiovascular events, which may be the collateral impacts of COVID-19 epidemic on HD patients.

Matching journals

The top 5 journals account for 50% of the predicted probability mass.

1
PLOS ONE
5266 papers in training set
Top 8%
19.7%
2
Health Science Reports
13 papers in training set
Top 0.1%
10.4%
3
Medicine
31 papers in training set
Top 0.1%
9.5%
4
Life
29 papers in training set
Top 0.1%
8.4%
5
Journal of Clinical Medicine
97 papers in training set
Top 0.5%
5.2%
50% of probability mass above
6
Scientific Reports
3612 papers in training set
Top 21%
4.6%
7
PLOS Neglected Tropical Diseases
466 papers in training set
Top 2%
3.7%
8
Journal of Translational Medicine
57 papers in training set
Top 0.2%
3.5%
9
IJID Regions
11 papers in training set
Top 0.1%
3.4%
10
Frontiers in Medicine
120 papers in training set
Top 0.8%
3.4%
11
Journal of Molecular Cell Biology
22 papers in training set
Top 0.1%
2.3%
12
Vaccines
198 papers in training set
Top 1%
2.3%
13
Kidney360
22 papers in training set
Top 0.3%
2.3%
14
BioMed Research International
28 papers in training set
Top 0.8%
1.8%
15
Cureus
68 papers in training set
Top 3%
1.5%
16
BMC Nephrology
18 papers in training set
Top 0.2%
1.2%
17
International Journal of Medical Informatics
26 papers in training set
Top 1%
1.1%
18
Clinical Journal of the American Society of Nephrology
10 papers in training set
Top 0.2%
1.1%
19
eLife
5828 papers in training set
Top 63%
0.9%
20
Journal of Medical Virology
140 papers in training set
Top 3%
0.7%
21
Emerging Infectious Diseases
105 papers in training set
Top 2%
0.5%
22
Frontiers in Pharmacology
111 papers in training set
Top 4%
0.5%
23
Kidney International Reports
15 papers in training set
Top 0.3%
0.5%
24
The FASEB Journal
194 papers in training set
Top 7%
0.5%
25
iScience
1154 papers in training set
Top 42%
0.5%